General Information of the Compound
Compound ID
CP0455463
Compound Name
2-[4-[6-[(4-methoxyphenyl)methyl]-2-pyridin-2-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]piperazin-1-yl]ethanol
    Show/Hide
Structure
Formula
C26H32N6O2
Molecular Weight
460.582
Canonical SMILES
COc1ccc(CN2CCc3nc(nc(N4CCN(CCO)CC4)c3C2)-c2ccccn2)cc1
    Show/Hide
InChI
InChI=1S/C26H32N6O2/c1-34-21-7-5-20(6-8-21)18-31-11-9-23-22(19-31)26(32-14-12-30(13-15-32)16-17-33)29-25(28-23)24-4-2-3-10-27-24/h2-8,10,33H,9,11-19H2,1H3
    Show/Hide
InChIKey
ZMGNNWMAKKNZDY-UHFFFAOYSA-N
Physicochemical Property
logP
2.2198
Rotatable Bonds
7
Heavy Atom Count
34
Polar Areas
77.85
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
8
Complexity
34

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 127041882
ChEMBL ID
CHEMBL3746769
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02042, Cystic fibrosis transmembrane conductance regulator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000535 CFBE41o- Homo sapiens (Human)  1
1
EC50 = 398.11 nM
   TI
   LI
   LO
   TS
CL000259 FRT Rattus norvegicus (Rat)  1
1
EC50 = 400 nM
   TI
   LI
   LO
   TS